Renal Cancer

Efficacy and Safety of Vorolanib plus Everolimus in Metastatic Renal Cell Carcinoma: A Three-Arm, Randomised, Double-Blind, Multicentre Phase III Study (CONCEPT) - Beyond the Abstract March 28, 2023

Radical Cystectomy and Urinary Diversion Outcomes in Patients with Single vs. Double Renal Unit: A 2:1 Matched-Pair Analysis - Beyond the Abstract March 28, 2023

Expression of PD-L1 in Renal Cancer, Prognostic Features and Clinical Utility of Its Routine Staining - Beyond the Abstract March 27, 2023

Incidence of Benign Renal Masses in a Contemporary Cohort of Patients Receiving Partial Nephrectomy for Presumed Renal Cell Carcinoma - Beyond the Abstract March 21, 2023

Oncocytoma on Renal Mass Biopsy: Is It Still the Same Histology When Surgery Is Performed? Results from UroCCR-104 Study - Beyond the Abstract February 28, 2023

Progression-free Survival after Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations - Beyond the Abstract February 1, 2023

Stereotactic Body Radiotherapy for Kidney Cancer: Ready for Prime Time? - Beyond the Abstract January 23, 2023

Nivolumab plus Ipilimumab plus Cabozantinib Triplet Combination for Patients with Previously Untreated Advanced Renal Cell Carcinoma: Results from a Discontinued Arm of the Phase III CheckMate 9ER Trial - Beyond the Abstract January 19, 2023

RE-VASC: An Adjuvant Scoring System in Diagnosis and Treatment of Renal Cell Carcinoma - Beyond the Abstract January 10, 2023

Epigenetics in Advanced Renal Cell Carcinoma: Potential New Targets - Beyond the Abstract January 6, 2023

Recurrence Pattern in Localized RCC: Results from a European Multicenter Database (RECUR) - Beyond the Abstract November 29, 2022

How to Optimize the Use of Adjuvant Pembrolizumab in Renal Cell Carcinoma: Which Patients Benefit the Most? - Beyond the Abstract November 28, 2022

Low Grade Oncocytic Tumors of the Kidney: A Clinically Relevant Approach for the Workup and Accurate Diagnosis - Beyond the Abstract November 2, 2022

Impact of Dedicated Renal Enhanced Recovery After Surgery (RERAS) Program on Postoperative Opioid Consumption and Evaluation of Surgeon-Specific Compliance to the Program - Beyond the Abstract November 1, 2022

CABOSEQ: The Effectiveness of Cabozantinib in Patients With Treatment Refractory Advanced Renal Cell Carcinoma: Results From the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) - Beyond the Abstract September 22, 2022

Screening Programs for Renal Cell Carcinoma: A Systematic Review by the EAU Young Academic Urologists Renal Cancer Working Group - Beyond the Abstract August 1, 2022

Therapeutic Potential of CDK4/6 Inhibitors in Renal Cell Carcinoma - Beyond the Abstract June 13, 2022

High Efficiency Capture of Biomarker miRNA15a for Noninvasive Diagnosis of Malignant Kidney Tumors - Beyond the Abstract May 19, 2022

Immunotherapy Salvage in mRCC Pretreated with Immunotherapy - Beyond the Abstract May 19, 2022

Cabozantinib in Patients with Advanced Renal Cell Carcinoma Primary Refractory to First-line Immunocombinations or Tyrosine Kinase Inhibitors - Beyond the Abstract May 11, 2022

Page 1 of 14